NCT03740334 2025-11-21
Ribociclib in Combination With Everolimus and Dexamethasone in Relapsed ALL
Dana-Farber Cancer Institute
Phase 1 Active not recruiting
Dana-Farber Cancer Institute
St. Jude Children's Research Hospital
Roswell Park Cancer Institute
Novartis
Novartis